Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
TEVA PHARMACEUTICAL INDUSTRIES LTD
Last earnings +11.9% on 2026-04-29
High leverage (liabilities/equity 4.2x).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
TEVA PHARMACEUTICAL INDUSTRIES LTD shows $17.3B in FY2025 revenue (+4.3% YoY), a 8.2% net margin, and 17.8% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000818686, latest 10-Q filed 2026-04-29) · EODHD · rules-based read · as of 6/18/2026, 5:10:53 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $15.9B | $14.9B | $15.8B | $16.5B | $17.3B |
| Gross profit | $7.59B | $6.97B | $7.64B | $8.06B | $8.94B |
| Operating income | $1.72B | -$2.20B | $433M | -$303M | $2.16B |
| Net income | $417M | -$2.45B | -$559M | -$1.64B | $1.41B |
| Diluted EPS | $0.38 | -$2.20 | -$0.50 | -$1.45 | $1.21 |
| Net margin | 2.6% | -16.4% | -3.5% | -9.9% | 8.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-11 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sell | 107K @ $34.10 | $3.63M |
| 2026-06-05 | BARER SOL J Director | Exercise | 21.7K | |
| 2026-06-05 | Lichtenstein Chen Director | Exercise | 14.5K | |
| 2026-06-05 | Crane Rosemary A Director | Exercise | 14.5K | |
| 2026-06-05 | Elstein Amir Director | Exercise | 14.5K | |
| 2026-06-05 | LIEBERMAN GERALD M Director | Exercise | 14.5K | |
| 2026-06-05 | Nisen Perry Director | Exercise | 14.5K | |
| 2026-06-05 | Satchi-Fainaro Ronit Director | Exercise | 14.5K |